GILD vs SGBX · P/E 18, rev $7.80B vs rev $5.0M
Gilead Sciences Inc (GILD) versus SG Blocks Inc (SGBX) — a side-by-side from cached financials, not a winner call.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US. It is led by Daniel P. O'Day.
SG Blocks Inc (SGBX) is a metal fabrication company listed on NASDAQ.
Latest reported GILD revenue for 2026-06-30 was $7.80B. Net income was -$10.50B. Revenue was up 12.1% from 2026-03-31 to 2026-06-30. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Latest reported SGBX revenue for 2024-12-31 was $5.0M. Net income was -$17.0M. Revenue was down 69.9% from 2023-12-31 to 2024-12-31. SGBX currently screens at market cap $9.3M.
GILD currently screens at market cap $160.15B and trailing P/E 17.5. SGBX currently screens at market cap $9.3M.
Not investment advice. Open the GILD and SGBX stock pages for the full models.
Not investment advice.